A low score means a worse functional outcome, while a higher score is correlated with better shoulder function.
After 1 year the presence of co-morbidities was a significant (p = 0.002) predictor for a poor functional outcome (mean HHS1 71.8 with co-morbidities, and 80.6 without co-morbidities).
††A third, negative, trial by Handolin et alw9 reported on a functional outcome, mean Olerud-Molander score, but did not provide the associated measure of variance to allow for statistical pooling.
They reported good functional outcome (mean MSTS score of 75.4 %), and 6 patients (60%%) were able to walk without a cane, three needed a cane, and one was wheelchair-bound because of ongoing pelvic pain.
Furthermore, the approach to antagonize IAP proteins in cancer cells, that is, via genetic manipulation of by pharmacological means, may affect the functional outcome.
Eighty-six per cent in the present study had good to excellent functional outcome with mean Haris hip score of 92.87, which is comparable to average scores (83 90) reported in the literature [23, 24, 25].
Another study compared mean time for healing and functional outcome in two groups of elderly women who had suffered osteoporotic pelvic fractures: one group received daily 100 μg parathyroid hormone (1 84) injections, while the other group received no treatment.
Mean time of hospital stay and functional outcome (with Harris hip score and Oxford hip score) were similar in both groups at the 1-year follow-up.
Recently, Nassif et al. [ 4] reported a similar technique in 6 patients, all of whom achieved bone union and a good functional outcome with a mean MSTS score of 72%%, although postoperative complications occurred in 4 patients (67 %): scar necrosis (n = 2), infection (n = 1), and screw breakage (n = 1).
The mean MAD of 21 mm appeared not to influence the quality of life or functional outcome scores despite the mean follow-up of 9 years.
